Doseology Sciences (FRA:VU70) Total Liabilities: €0.05 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VU70 Doseology Sciences Inc FRA:VU70
36 GF Score
Price €0.06
GF Value €0.10
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences Total Liabilities?

Doseology Sciences FRA:VU70 36 Total Liabilities is €0.05 Mil as of Mar. 2026. GuruFocus rates FRA:VU70 with a GF Score™ of 36/100 and a GF Value™ of €0.10. The stock has 5 warning signs investors should review.

Doseology Sciences's Total Liabilities for the quarter that ended in Mar. 2026 was €0.05 Mil.

Doseology Sciences's quarterly Total Liabilities declined from Sep. 2025 (€0.07 Mil) to Dec. 2025 (€0.05 Mil) but then increased from Dec. 2025 (€0.05 Mil) to Mar. 2026 (€0.05 Mil).

Doseology Sciences's annual Total Liabilities declined from Jun. 2023 (€0.07 Mil) to Jun. 2024 (€0.06 Mil) but then increased from Jun. 2024 (€0.06 Mil) to Jun. 2025 (€0.06 Mil).

Doseology Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Doseology Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doseology Sciences Total Liabilities Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial 2.32 0.64 0.07 0.06 0.06

Doseology Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.06 0.07 0.05 0.05
FRA:VU70
36GF Score
Doseology Sciences Inc FRA:VU70
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doseology Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Doseology Sciences's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.06+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.06

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=0.946-0.887
=0.06

Doseology Sciences's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.051+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.05

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=0.745-0.694
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.05 Mil mean?
Doseology Sciences (FRA:VU70) has a Total Liabilities of €0.05 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Doseology Sciences and its competitors.
Is Doseology Sciences' Total Liabilities too high?
Doseology Sciences' current Total Liabilities is €0.05 Mil. Overall, Doseology Sciences has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' Total Liabilities compare to VRTX and REGN?
Doseology Sciences' Total Liabilities of €0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Doseology Sciences and its competitors. Doseology Sciences's current Total Liabilities is €0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Doseology Sciences (FRA:VU70) has a current Total Liabilities of €0.05 Mil. The stock's GF Value™ is €0.10, compared to a current price of €0.06 — trading 36.5% below its estimated fair value. The current Total Liabilities is €0.05 Mil. Doseology Sciences' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Doseology Sciences (FRA:VU70), the current Total Liabilities is €0.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (FRA:VU70) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of €0.06 is trading 36.5% below its estimated GF Value™ of €0.10.

Key valuation signals for FRA:VU70:

  • Total Liabilities: €0.05 Mil
  • GF Value™: €0.10 vs. price of €0.06 (36.5% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the FRA:VU70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges DOSEF:USAMOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
36GF Score

Get the complete analysis for FRA:VU70

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price
€0.10
GF Value